GSK3B and stroke disorder: Current evidence indicates that NBP promotes post‐stroke angiogenesis through multiple pathways, including Shh and HIF‐1α/VEGF signaling [9, 10, 41], however, the involvement of the Akt/GSK‐3β/β‐catenin pathway remains to be elucidated.